Calidi Biotherapeutics (CLDI) Minority Interest (2024 - 2025)
Calidi Biotherapeutics (CLDI) posted quarterly Minority Interest of $280000.0 for Q3 2025, down 42.27% year-over-year from $485000.0 in Q3 2024, and down 10.26% quarter-over-quarter from $312000.0 in Q2 2025.
Calidi Biotherapeutics (CLDI) Minority Interest (2024 - 2025) Analysis & Trends
Calidi Biotherapeutics' Minority Interest history runs 2 years deep, the most recent figure standing at $280000.0 for Q3 2025.
- In Q3 2025, Minority Interest fell 42.27% year-over-year to $280000.0; the TTM figure through Sep 2025 stood at $280000.0 (down 42.27% YoY), while the FY2024 annual figure was $434000.0, changed N/A from the prior year.
- Minority Interest for Q3 2025 stood at $280000.0, down from $312000.0 in the prior quarter.
- The five-year high for Minority Interest was $485000.0 in Q3 2024, with the low at $280000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 280,000.00 |
| Jun 30, 2025 | 312,000.00 |
| Mar 31, 2025 | 358,000.00 |
| Dec 31, 2024 | 434,000.00 |
| Sep 30, 2024 | 485,000.00 |